J Acad Nutr Diet. 2018 Apr;118(4):637-651. doi: 10.1016/j.jand.2016.09.036. Epub 2016 Dec 1.
Epidemiologic studies have reported conflicting findings between soy- and legume-derived dietary isoflavones and risk of endometrial cancer.
The aim of the present meta-analysis was to quantitatively investigate the association between daily intake of soy- and legume-derived isoflavones and risk of endometrial cancer.
A broad search was conducted in the following electronic databases: PubMed, EMBASE, Google Scholar, the Cochrane Library, the China Knowledge Resource Integrated Database, and the Chinese Biomedical Database based on combinations of the key words endometrial cancer, isoflavone, soy, and legume for epidemiologic studies that focused on relationships between dietary isoflavones and endometrial cancer risk. A fixed-effect or random-effect model was used to pool study-specific risk estimates.
A total of 13 epidemiologic studies were included in the present meta-analysis, consisting of three prospective cohort studies and 10 population-based case-control studies. The final results indicated that higher dietary isoflavone levels from soy products and legumes were associated with a reduced risk of endometrial cancer (odds ratio [OR] 0.81, 95% CI 0.74 to 0.89). Low heterogeneous bias was observed (I=11.7%; P=0.327). Subgroup analyses were conducted based on study design, source of dietary isoflavones, and study region. When restricted to study design, dietary isoflavones from soy and legumes played a role in prevention of endometrial cancer in case-control studies (OR 0.81, 95% CI 0.73 to 0.90). However, there did not appear to be an association between dietary isoflavones and endometrial cancer in cohort studies (OR 0.81, 95% CI 0.66 to 1.00). Significant associations were found between dietary isoflavones from soy products (OR 0.82, 95% CI 0.72 to 0.92) and legumes (OR 0.84, 95% CI 0.74 to 0.96) and endometrial cancer. Dietary isoflavones were associated with reduced incidence of endometrial cancer, both in Asian countries (OR 0.78, 95% CI 0.66 to 0.93) and non-Asian countries (OR 0.82, 95% CI 0.73 to 0.92).
The findings suggest a weak inverse association between higher consumption of dietary isoflavones from soy products and legumes and endometrial cancer risk. However, there is still a need for large, prospective epidemiologic studies that provide a higher level of evidence to verify these findings.
流行病学研究报告称,大豆和豆类来源的膳食异黄酮与子宫内膜癌风险之间存在相互矛盾的结果。
本荟萃分析的目的是定量研究大豆和豆类来源的异黄酮的每日摄入量与子宫内膜癌风险之间的关系。
基于关键词“子宫内膜癌”、“异黄酮”、“大豆”和“豆类”,在以下电子数据库中进行了广泛的搜索:PubMed、EMBASE、Google Scholar、Cochrane 图书馆、中国知识资源综合数据库和中国生物医学数据库,以搜索针对饮食异黄酮与子宫内膜癌风险之间关系的流行病学研究。使用固定效应或随机效应模型来汇总研究特定的风险估计值。
本荟萃分析共纳入了 13 项流行病学研究,包括 3 项前瞻性队列研究和 10 项基于人群的病例对照研究。最终结果表明,较高的大豆制品和豆类来源的膳食异黄酮水平与子宫内膜癌风险降低相关(比值比 [OR] 0.81,95%置信区间 [CI] 0.74 至 0.89)。观察到低异质性偏倚(I=11.7%;P=0.327)。根据研究设计、膳食异黄酮来源和研究区域进行了亚组分析。当仅限于研究设计时,大豆和豆类的膳食异黄酮在病例对照研究中发挥了预防子宫内膜癌的作用(OR 0.81,95%CI 0.73 至 0.90)。然而,在队列研究中,膳食异黄酮似乎与子宫内膜癌之间没有关联(OR 0.81,95%CI 0.66 至 1.00)。大豆制品(OR 0.82,95%CI 0.72 至 0.92)和豆类(OR 0.84,95%CI 0.74 至 0.96)来源的膳食异黄酮与子宫内膜癌之间存在显著关联。膳食异黄酮与子宫内膜癌的发生率降低有关,无论是在亚洲国家(OR 0.78,95%CI 0.66 至 0.93)还是非亚洲国家(OR 0.82,95%CI 0.73 至 0.92)。
这些发现表明,大豆制品和豆类来源的膳食异黄酮摄入量较高与子宫内膜癌风险之间存在较弱的负相关关系。然而,仍然需要更大规模的前瞻性流行病学研究,以提供更高水平的证据来验证这些发现。